Delfi Diagnostics: Funding, Investors & Team (Sep 2026)
Delfi Diagnostics identify disease early, when it is generally reparable, utilizing high accuracy harmless blood tests. It utilizes computerized reasoning and genome sequencing to distinguish extraordinary examples of DNA discontinuity in the blood of patients.
Delfi Diagnostics has raised $259M across 2 funding rounds on record, the most recent an undisclosed round of $34.3M announced in Dec 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Delfi Diagnostics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Delfi Diagnostics Funding Rounds
Delfi Diagnostics raised $225M in a Series B announced in Jul 2022.
3.4 years later, an undisclosed round of $34.3M was announced in Dec 2025.
Delfi Diagnostics Founders and Leadership Team
No contact details are on record for this team yet.
Delfi Diagnostics Funding Compared to Other Biotechnology Startups
Delfi Diagnostics' latest round of $34.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Delfi Diagnostics in Biotechnology and Baltimore
Companies Similar to Delfi Diagnostics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Delfi Diagnostics Funding FAQs
What does Delfi Diagnostics do?
Delfi Diagnostics identify disease early, when it is generally reparable, utilizing high accuracy harmless blood tests. It utilizes computerized reasoning and genome sequencing to distinguish extraordinary examples of DNA discontinuity in the blood of patients.
How much funding has Delfi Diagnostics raised?
Delfi Diagnostics has raised $259M across 2 rounds on record. The most recent is an undisclosed round of $34.3M announced in Dec 2025.
When did Delfi Diagnostics last raise funding?
Delfi Diagnostics' most recent funding round on record is an undisclosed round of $34.3M, announced in Dec 2025.
Who is the CEO of Delfi Diagnostics?
Victor Velculescu is listed as CEO at Delfi Diagnostics.
Where is Delfi Diagnostics headquartered?
Delfi Diagnostics is based in Baltimore, Maryland, United States.
How many employees does Delfi Diagnostics have?
Delfi Diagnostics is in the 101-250 employee band.
How does Delfi Diagnostics' funding compare to other Biotechnology startups?
Delfi Diagnostics' latest round of $34.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Delfi Diagnostics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Delfi Diagnostics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.